Delivery Order SPE2DB20D1102-SPE2DB24FC6RV

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of naloxone 0.4 mg/ml vials. The contract has a total ceiling value of $1,761.46 and is a firm fixed-price type contract. The period of performance extends through June 21, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Naloxone 0.4 mg/mL vials. The contract has a ceiling value of $5,132.76 and a performance period through April 12, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of naloxone 0.4 mg/ml vials. The award has a ceiling value of $1,815.13 and is a firm fixed-price contract. The order is placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,118,754 units of the drug naloxone 2 mg/2 ml syringe, with a ceiling value of $6,448.79. The contract is a firm fixed-price delivery order, with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,018.19, is for the supply of 4,567,448,573 units of 2 mg/2 mL naloxone syringes. The order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,097.84, is for the delivery of 0.4 mg/mL vials of the opioid antagonist drug naloxone. This is a firm fixed-price delivery order contract with a period of performance through March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone 2 mg/2 ml syringes, with a ceiling value of $1,224.45 and a period of performance through June 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,997.43, is for the delivery of 4,563,961,640 units of naloxone 0.4mg/10ml solution in boxes of 10. This is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 0.4 mg/mL Naloxone vials. The $2,799.99 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a completion date of July 23, 2024 and does not have a set-aside designation. Amerisourcebergen is a significant supplier of pharmaceuticals and medical supplies to various government...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $3,091.99 firm-fixed-price contract is for the delivery of NALOXONE 0.4 MG/ML VIA, with a completion date of June 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB24FC6RV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 0.4 mg/mL naloxone vials. The delivery order, valued at $1,674.64, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is set to expire in December 2025. This contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the naloxone vials to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through this delivery order, which has a completion date of July 17, 2024.

Generated 10/15/24, 9:38 PM